Cancer Cures Not Coming For Minorities
Wednesday, September 14, 2011
For Immediate Release:
|
 |
| |
| Cancer
Cures Not Coming For Minorities |
| |
San Francisco, CA -
September 14, 2011--
WHAT: "Cancer Cures Not Coming For Minorities" - Learn
the Importance of FDA Clinical Trials for Minority Cancers... Why Do
Minorities Die From Cancer More Often Than Whites ?
WHO: Dana Dornsife, World Philanthropist/Founder of
Lazarex Cancer Foundation and Legendary R&B Vocalist Lenny Williams
WHEN: Available For Interviews In-Studio or Via Phone
or see below PR.
BACKGROUND:
Dornsife is the founder and president of Lazarex Cancer Foundation and
Williams was the lead singer for the soul band, Tower of Power. Both
have had family members who have lost battles with cancer. They are
available to discuss in-depth why there are higher incidences of cancer
deaths among Hispanics and African-Americans - due to cultural
differences. They can discuss grave misconceptions about cancer
detection and survival, as well as the lack of financial resources which
have allowed cancer to become more prevalent and more deadly amongst the
minority population.
Although participation in FDA clinical trials could help save more
African-American lives, blacks have traditionally eschewed medical
trials. This is due to decades-old myths and stories of mistreatment of
minorities by the medical community. Lazarex intends to reverse this
view.
Cancer's dirty little secret needs to come into the light. The disregard
that many African-Americans and Hispanics have for cancer awareness
needs to stop. The movement to save more lives begins with learning the
facts about early detection and the importance of FDA clinical trials.
Knowing the truth about cancer can improve everyones chances for beating
it.
TESTIMONIAL: Doctors told 14 year old Brittani that there was no more
that they could do for her -
www.youtube.com/watch?v=P188FST1Vzo
Kirk Meyer, Press Release 9/11/11
kirksepromo@yahoo.com
925 330 2459
Danville ,Ca.
Cancer Cures Slow in Coming for African Americans
Clinical trials provide valuable information when it comes to diseases
like cancer. Clinical trials are used to test the safety and
effectiveness of drugs, devices and procedures. Participants in clinical
trials are often given access to new treatments and procedures not yet
available to the public. The results from clinical trials help develop
better methods of cancer treatment and cancer screenings. These trials
are open to anyone who qualifies, yet research suggests that African
American participation in clinical trials is extremely low. Breast,
colon/rectal, lung, and prostate cancer are the most fatal cancers
impacting African Americans. Greater participation in these studies
would provide valuable data to help fight cancer in the African American
community. According to the American Cancer Society, breast cancer is
the most common cancer with the highest death rate among African
American women, while African American men have the highest incidence
of, and death from, prostate cancer.
Given the gross under representation of African Americans in clinical
trials, Lazarex Cancer Foundation is pleased to announce a new program
to bridge the gap in cancer care for the African American community.
Lazarex aims to increase the percentage of African Americans in cancer
screenings and clinical trials by addressing the barriers that prevent
them from participating. R&B singer Lenny Williams has graciously agreed
to help the foundation by acting as an Ambassador to spread the word
about the importance of clinical trials and cancer screenings within the
African American community. Dana Dornsife, founder and president of
Lazarex Cancer Foundation, echoes the importance of screenings for
earlier detection and better treatment options. Early detection of
cancer generally improves the odds of recovery and survival. In studies
comparing cancer survival and mortality among various ethnic groups it
is clear that a higher percentage of African Americans are diagnosed in
advanced stages of cancer, resulting in lower rates of survival. Dana
Dornsife emphasizes this point by pointing out that "cancer is color
blind" and needs to be addressed across all populations.
The primary mission of Lazarex Cancer Foundation is to provide financial
assistance to help defray the costs associated with end stage cancer
patient participation in FDA approved clinical trials. Costs like
airfare, lodging and ground transportation all too often present
insurmountable obstacles. The foundation also helps cancer patients
navigate and identify their clinical trial options. Education and
outreach are fast becoming a new focus of the foundation's efforts,
especially amongst minority populations. Lazarex helps patients learn
how clinical trials work and what to expect.
The goal of Lazarex Cancer Foundation is to let cancer patients know
that there is hope, regardless of race, gender or ethnic background. The
fact is that cancer research and clinical trials are only effective
across the board if cancer patients of both sexes, all ages and ethnic
groups are represented. The foundation helps cancer patients from all
walks of life, in all age groups, with all forms of cancer. This
includes reaching out to patients in all income brackets to inform them
that their participation plays an important role in the fight against
cancer.
For additional information, please visit the Lazarex Cancer Foundation
website: www.lazarex.org.
Kirk Meyer
Kirksepromo@yahoo.com
925 330 2459
Danville ,Ca.
###
|
|
|
Total Views: 456 |
 |
Online Hits: 398 |
 |
RSS Hits: 58 |
|
|
|
Search
Google for related stories: |
|
|
|
|
Custom Search
|
|
